Breaking: Mizuho Securities Reaffirms $97.0000 Price Target On IQVIA Holdings Inc (IQV) Shares, Reaffirms Their Original “Hold” Rating

May 22, 2018 - By Vivian Park

IQVIA Holdings Inc (IQV) Rating Reaffirmed

Recently, In a research note revealed to investors and clients on 17 May, IQVIA Holdings Inc (IQV) shares have had their “Hold” Rating reaffirmed by stock research analysts at Mizuho Securities, who currently has a $97.0000 PT on company. This target by Mizuho Securities suggests the possibile downside of -5.52 % from the last stock price.

IQVIA Holdings Inc. (NYSE:IQV) Ratings Coverage

Among 12 analysts covering IQVIA Holdings (IQV), 7 have Buy rating, 0 Sell and 5 Hold. Therefore 58% are positive. IQVIA Holdings has $12800 highest and $97.0 lowest target. $112.09’s average target is 9.18% above currents $102.67 stock price. IQVIA Holdings had 14 analyst reports since December 15, 2017 according to SRatingsIntel. The rating was maintained by Piper Jaffray on Thursday, February 15 with “Hold”. The stock has “Buy” rating by Goldman Sachs on Friday, April 13. The stock of IQVIA Holdings Inc. (NYSE:IQV) has “Buy” rating given on Monday, April 9 by Argus Research. As per Thursday, February 15, the company rating was maintained by JP Morgan. On Wednesday, January 24 the stock rating was maintained by Mizuho with “Hold”. The company was maintained on Thursday, February 15 by Robert W. Baird. SunTrust maintained the shares of IQV in report on Monday, January 22 with “Hold” rating. The rating was upgraded by SunTrust to “Buy” on Wednesday, March 7. The firm earned “Hold” rating on Thursday, December 14 by MUFG Securities Americas Inc. The rating was maintained by RBC Capital Markets on Thursday, February 15 with “Buy”.

The stock increased 0.45% or $0.46 during the last trading session, reaching $102.67. About 92,010 shares traded. IQVIA Holdings Inc. (IQV) has risen 27.14% since May 22, 2017 and is uptrending. It has outperformed by 15.59% the S&P500.

Analysts await IQVIA Holdings Inc. (NYSE:IQV) to report earnings on August, 2. They expect $1.14 EPS, up 4.59 % or $0.05 from last year’s $1.09 per share. IQV’s profit will be $233.30M for 22.52 P/E if the $1.14 EPS becomes a reality. After $1.24 actual EPS reported by IQVIA Holdings Inc. for the previous quarter, Wall Street now forecasts -8.06 % negative EPS growth.

Quintiles IMS Holdings, Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. The company has market cap of $21.01 billion. It operates through three divisions: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. It has a 17.46 P/E ratio. The Commercial Solutions segment offers country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order to life science companies, and investment and financial sectors that deal with life science companies; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level to pharmaceutical sales organizations.

More recent IQVIA Holdings Inc. (NYSE:IQV) news were published by: Streetinsider.com which released: “IQVIA Holdings (IQV) Secures Technology Platform Contract from PruGen Pharmaceuticals for Advanced Field Sales …” on May 18, 2018. Also Businesswire.com published the news titled: “IQVIA Reaffirms Its Second-Quarter and Full-Year 2018 Guidance, Including Adjusted EPS Growth of 13.6% to 20.4 …” on May 18, 2018. Seekingalpha.com‘s news article titled: “Tracking Glenn Greenberg’s Brave Warrior Advisors Portfolio – Q1 2018 Update” with publication date: May 18, 2018 was also an interesting one.

IQVIA Holdings Inc. (NYSE:IQV) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.